PATENT CLAIM ANALYSIS

Application Number: 16049541
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["435", "006100"]

Abstract:
FRET-labeled compounds are provided for use in analytical reactions. In certain embodiments, FRET-labeled nucleotide analogs are used in place of naturally occurring nucleoside triphosphates or other analogs in analytical reactions comprising nucleic acids, for example, template-directed nucleic acid synthesis, DNA sequencing, RNA sequencing, single-base identification, hybridization, binding assays, and other analytical reactions.

Claim (Index 25):
The kit of  claim 22 , wherein the first and second FRET efficiencies are from about 0 to about 100% of a maximum FRET efficiency for each of the first and second FRET labels.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.53659
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15379118', '13427611', '12749859', '14633094', '12967507']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6587431685132937
- 35 USC 102 Novelty (BERT): 0.5756757627971965
- Combined Prediction Score: 0.650436427941684
- Mean Citation Score: 420.443488
- Max Citation Score: 523.9585
- Similarity Product: 352.92874240201706

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test